HomePress-release
Redding, California - February 26, 2025

Côte d'Ivoire IVD Market to be Worth $25.8 Billion by 2032

Côte d'Ivoire IVD Market by Offering, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User - Forecast to 2032


Meticulous Research®—a leading global market research company, published a research report titled Côte d'Ivoire IVD Market by Offering, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User Forecast to 2032. According to this latest publication from Meticulous Research®, the Côte d'Ivoire IVD market is expected to reach $25.8 billion by 2032, at a CAGR of 2.6% from 2025 to 2032.

The increasing burden of infectious diseases, rising government support and international aid, advancements in diagnostic technologies, and rising health awareness and population growth are factors driving the growth of the Côte d'Ivoire IVD market. However, market growth is restrained by the high costs of advanced technologies and limited healthcare infrastructure.

In addition, Public-private partnerships (PPP), rising demand for molecular diagnostics, telemedicine and point-of-care testing, and rising awareness of early diagnosis provide considerable potential opportunities for market players. The market faces substantial challenges including economic constraints, and supply chain and logistic issues.

Key Players

The key players operating in the Côte d'Ivoire IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc., (U.S.), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), The Kenya Medical Research Institute (KEMRI), Biovet Ltd., and Laboratories & Allied Ltd

The Côte d'Ivoire IVD market is segmented by Offering, Technology, Application, Diagnostic Approach, and by End User.  The study also evaluates industry competitors and analyzes the market at the country levels.

By Offering, in 2025, the reagents & kits segment is expected to account for the largest share of the Côte d'Ivoire IVD market. The large market share of this segment is attributed to the recurring use of assays & kits in the detection of various chronic diseases, the commercial availability of a diverse range of reagents & consumables for the diagnosis of various diseases, and the increase in the volume of testing for infectious diseases such as COVID-19 and influenza.

By Technology, in 2025, the immunoassay/immunochemistry segment is expected to account for the largest share of Côte d'Ivoire IVD market. The segment’s large share is driven by the benefits of immunoassay technologies, such as efficient, convenient, and accurate research tools for the detection and quantitation of targets, continuous development of new biomarkers, and cost-effectiveness, coupled with the growing adoption of automated platforms for ELISA. ELISA consists of techniques such as chemiluminescence, fluorescence, and colorimetric immunoassays. The benefits of immunoassay technologies, such as efficient, convenient, and accurate research tools for the detection and quantitation of targets, continuous development of new biomarkers, and cost-effectiveness, coupled with the growing adoption of automated platforms for ELISA are expected to increase the adoption of this technology.

By End User, in 2025, the hospitals & clinics segment is expected to account for the largest share of the Côte d'Ivoire IVD market. The largest share of the segment is attributed to the increase in the number of hospitals & clinics, the rising patient population, the increasing prevalence of infectious diseases, and the rise in funding for the expansion of hospital infrastructure. Further, in the country, the government is actively enhancing healthcare infrastructure to improve diagnostic services. In February 2024, the International Finance Corporation (IFC) partnered with the Ivorian government to develop public-private partnerships aimed at providing affordable, high-quality laboratory and imaging services in 14 public hospitals across the Abidjan and Abengourou regions.

Download Sample Report Here @  https://www.meticulousresearch.com/download-sample-report/cp_id=6135

Key questions answered in the report-

  • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, and by end user?
  • What was the historical market size for the Côte d'Ivoire IVD market?
  • What are the market forecasts and estimates for the period 2024–2031?
  • What are the major drivers, restraints, challenges, opportunities, and trends in the Côte d'Ivoire IVD market?
  • Who are the major players in the Côte d'Ivoire IVD market?
  • What is the competitive landscape like and who are the market leaders in the Côte d'Ivoire IVD market?
  • What are the recent developments in the Côte d'Ivoire IVD market?
  • What are the different strategies adopted by the major players in the Côte d'Ivoire IVD market?

Contact Us:
Meticulous Research®

Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Recommended Readings

  Download Free Sample
Table Of Content
Download Free Sample Report